首页> 外文期刊>Nutrition in clinical practice: official publication of the American Society for Parenteral and Enteral Nutrition >Perioperative Alanyl-Glutamine-Supplemented Parenteral Nutrition in Chronic Radiation Enteritis Patients With Surgical Intestinal Obstruction: A Prospective, Randomized, Controlled Study
【24h】

Perioperative Alanyl-Glutamine-Supplemented Parenteral Nutrition in Chronic Radiation Enteritis Patients With Surgical Intestinal Obstruction: A Prospective, Randomized, Controlled Study

机译:慢性放射性肠炎伴手术肠梗阻的围手术期丙氨酰谷氨酰胺补充胃肠外营养:一项前瞻性,随机,对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: A prospective, randomized, controlled study was performed to evaluate the effects of perioperative alanyl-glutamine-supplemented parenteral nutrition (PN) support on the immunologic function, intestinal permeability, and nutrition status of surgical patients with chronic radiation enteritis (CRE)-induced intestinal obstruction. Methods: Patients who received 0.4 g/kg/d alanyl-glutamine and isonitrogenous PN were assigned to an alanyl-glutamine-supplemented PN (Gln-PN) group and a control group, respectively. Serum levels of alanine aminotransferase and glutamine, body fat mass (FM), immunologic function, and intestinal permeability were measured before and after surgery. Results: Serum glutamine levels of the Gln-PN group significantly exceeded that of the control group (P < .001; Gln-PN, baseline 460.7 +/- 42.5 vs 523.3 +/- 48.6 mu mol/L on postoperative day 14 [POD14], P < .001; control, baseline 451.9 +/- 44.0 vs 453.8 +/- 42.3 mu mol/L on POD14, P = .708). Lactulose/mannitol ratios of both groups decreased over time (Gln-PN, baseline 0.129 +/- 0.0403 vs 0.024 +/- 0.0107 on POD1 4; control, baseline 0.125 +/- 0.0378 vs 0.044 +/- 0.0126 on POD14, P < .001 in both groups). CD4/CD8-positive T-lymphocyte ratios significantly rose in both groups, with significant intergroup difference (P < .001; Gln-PN, baseline 1.36 +/- 0.32 vs 1.82 +/- 0.30 on POD14, P < .001; control, baseline 1.37 +/- 0.25 vs 1.63 +/- 0.31 on POD14, P < .001). In the Gln-PN group, FM increased from 3.68 +/- 1.68 kg at baseline to 5.22 +/- 1.42 kg on POD14 (P < .001). FM of control group increased from 3.84 +/- 1.57 kg at baseline to 5.40 +/- 1.54 kg on POD14 (P < .001). However, there were no significant intergroup differences (P = .614). Conclusion: Gln-PN significantly boosted the immune state and decreased the intestinal permeability of CRE patients. However, Gln-PN was not superior to standard PN in improving the nutrition state and intestinal motility of surgical patients with CRE-induced intestinal obstruction.
机译:背景:进行了一项前瞻性,随机对照研究,以评估围手术期补充丙氨酰-谷氨酰胺的肠外营养(PN)支持对慢性放射性肠炎(CRE)-手术患者的免疫功能,肠通透性和营养状况的影响-引起肠梗阻。方法:将接受0.4 g / kg / d丙氨酰-谷氨酰胺和等氮PN的患者分别分为补充丙氨酰-谷氨酰胺的PN(Gln-PN)组和对照组。术前和术后测量血清丙氨酸氨基转移酶和谷氨酰胺水平,人体脂肪量(FM),免疫功能和肠通透性。结果:Gln-PN组的血清谷氨酰胺水平显着超过对照组(P <.001; Gln-PN,术后第14天基线为460.7 +/- 42.5 vs 523.3 +/- 48.6μmol/ L [POD14 ],P <.001;对照,基线为451.9 +/- 44.0,相对于POD14上的453.8 +/-42.3μmol/ L,P = .708)。两组的乳果糖/甘露醇比率随时间下降(Gln-PN,基线为0.129 +/- 0.0403,而POD1 4为0.024 +/- 0.0107;对照组,基线为0.125 +/- 0.0378,而POD14的基线为0.044 +/- 0.0126,P <两组均为.001)。两组的CD4 / CD8阳性T淋巴细胞比率均显着上升,组间差异显着(P <.001; Gln-PN,基线1.36 +/- 0.32,而POD14的基线为1.82 +/- 0.30,P <.001;对照,基线为1.37 +/- 0.25,而POD14为1.63 +/- 0.31,P <.001)。在Gln-PN组中,FM从基线时的3.68 +/- 1.68千克增加到POD14上的5.22 +/- 1.42千克(P <.001)。对照组的FM从基线时的3.84 +/- 1.57千克增加到POD14上的5.40 +/- 1.54千克(P <.001)。但是,组间没有显着差异(P = .614)。结论:Gln-PN可显着增强CRE患者的免疫状态并降低其肠通透性。然而,Gln-PN在改善CRE引起的肠梗阻手术患者的营养状态和肠蠕动方面并不优于标准PN。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号